Related Experiment Video
Updated: Jan 18, 2026

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
Design, Synthesis and Alpha-glucosidase Inhibitory Effect of Pyrazole-1,2,3-Triazole Hybrids
Suprapaneni Sirisha1, Nagaraju Kerru1,2, Ramakrishna Rao Bhonsle1
1Department of Chemistry, GITAM School of Sciences, GITAM University, Bengaluru, India.
Abstract:
A novel pyrazole-1,2,3-triazole hybrids were developed and evaluated for its glucosidase inhibitory effects. The targeted 1,2,3-triazole hybrids were obtained from the copper-catalyzed reaction between azide and pyrazole alkyne in dichloromethane at room temperature. Compounds with 4-nitro and 4-chloro groups, respectively, proved the most significant, promising α-glucosidase inhibition activity with IC50 values of 3.35 and 6.58 µM, related to the cited inhibitor, acarbose (IC50 = 3.86 µM). Further, molecular docking studies of the most active compounds were carried out, and the results demonstrated considerable binding modes in the active site of the human lysosomal acid-alpha-glucosidase enzyme. In addition, the density functional theory was carried out to predict the electronic properties of active ligands. Structure-activity relationship analysis implied that the electron-leaving functions at the para position account for the variable enzyme inhibition. Therefore, developing novel therapeutic agents may assist as structural models in exploring diabetes mellitus.
More Related Videos
10:17Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones
Published on: February 7, 2019
07:12Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions
Published on: July 17, 2020
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: Glinides